Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMPAGLIFLOZIN Cause Wrong product administered? 9 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Wrong product administered have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.0% of all adverse event reports for EMPAGLIFLOZIN.

9
Reports of Wrong product administered with EMPAGLIFLOZIN
0.0%
of all EMPAGLIFLOZIN reports
0
Deaths
1
Hospitalizations

How Dangerous Is Wrong product administered From EMPAGLIFLOZIN?

Of the 9 reports, 1 (11.1%) required hospitalization.

Is Wrong product administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does EMPAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,644) Fungal infection (1,941) Blood glucose increased (1,797) Euglycaemic diabetic ketoacidosis (1,769) Weight decreased (1,661) Urinary tract infection (1,439) Ketoacidosis (1,411) Dizziness (1,372) Nausea (1,333) Vomiting (1,201)

What Other Drugs Cause Wrong product administered?

INSULIN LISPRO (337) INSULIN GLARGINE (226) RISPERIDONE (141) QUETIAPINE (137) ACETAMINOPHEN (133) INSULIN ASPART (112) CLOZAPINE (106) INSULIN HUMAN (104) TUBERCULIN PURIFIED PROTEIN DERIVATIVE (104) IBUPROFEN (102)

Which EMPAGLIFLOZIN Alternatives Have Lower Wrong product administered Risk?

EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN EMPAGLIFLOZIN vs EMSAM EMPAGLIFLOZIN vs EMTRICITABINE

Related Pages

EMPAGLIFLOZIN Full Profile All Wrong product administered Reports All Drugs Causing Wrong product administered EMPAGLIFLOZIN Demographics